Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 1998

View Archived Issues

Ono's new MMP inhibitors

Ebselen: neuroprotective agent in patients with neurological deficits after aneurysmal hemorrhage

Stavudine versus zidovudine therapy in HIV-1-infected pediatric patients

Spironolactone and Diane 35 may have synergistic effects in hirsutism

ARL-15849KF: a selective CCK-A agonist for the treatment of eating disorders

Efficacy and safety of long-term donepezil in patients with mild to moderate AD

Company Profile: CeNeS

Sumitomo claims compounds for treating reperfusion injury

Xenova: year-end 1997 highlights

Ribi ImmunoChem and Schering-Plough sign distribution agreement for Melacine

EchoGen up for discussion by CPMP and FDA advisory committee

Verapamil analogues reverse MDR in cancer cells

Indazole inhibitors of PDE IV and TNF from Pfizer

Lilly develops selective serotonergic agents

Lilly describes novel compounds for postmenopausal syndrome and related conditions

European patent covers Bayer's new HMG-CoA reductase inhibitors

Faes reveals new antihistamines

AII blocker prevents complications of hypertension in SHR

Taiwan researchers identify lead potassium channel opener selective for bladder

UPSA discloses antiinflammatory/analgesic 1,2-diarylindole derivatives

EntreMed's therapy for insufficient tissue oxygenation heading for clinic

Modified factor VII interrupts the coagulation cascade

Selective iNOS inhibitor improves hepatic circulation and oxygen metabolism in sepsis

Cambridge NeuroScience remains optimistic about the potential of Cerestat

Still hot news: Immunex's Enbrel

Cel-Sci expands North American clinical trial for Multikine

Morphogenesis awarded phase I SBIR grant

Anticancer drug discovery collaboration initiated by Tripos, MDS Panlabs and Cell Pathways

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...